Objective:

To discuss the implications of the in-source fragmentation (ISF) findings by Giera et al. and the subsequent debate regarding the existence and significance of the dark metabolome, including perspectives from researchers in the field.

Approach:

• Interview with Researchers: Engaged with Yasin El Abiead and Pieter C. Dorrestein to explore their perspectives on the claims made by Giera et al. and the media coverage surrounding it.

Key Findings:

• Giera et al. claim that ISF accounts for over 70% of peaks in LC-MS/MS metabolomic datasets, challenging the assumption that most peaks correspond to unique metabolites.
• El Abiead and Dorrestein argue that this claim has led to negative consequences for research funding and publication in metabolomics, emphasizing the need for careful interpretation.
• ISF is a well-documented phenomenon, and the extent of ISF varies based on multiple factors, including chemical structure and instrument design.
• Studies examining ISF in biological samples report lower rates (2-36%) compared to the 70% figure from Giera et al., indicating a discrepancy in findings.
• The recent preprint by Chi et al. suggests that approximately 10% of features arise from ISF, aligning more closely with previous studies and highlighting the need for further investigation.

Interpretation:

The debate underscores the importance of careful interpretation of ISF data and its implications for understanding the metabolome.

Limitations:

• The original study by Giera et al. used a compound library that may not represent real biological samples, limiting the applicability of the findings.
• The lack of publicly available raw data and compound structures restricts a comprehensive assessment of the findings and their implications.

Conclusion:

The discussion emphasizes the complexity of the metabolome and the necessity of optimizing instrument settings to accurately assess ISF.

Sources:

• The Analytical Scientist
• Nature Metabolism